IXICO (LON:IXI) Trading Up 11.1% – What’s Next?

Shares of IXICO plc (LON:IXI) traded up 11.1% on Tuesday . The company traded as high as GBX 10 ($0.13) and last traded at GBX 10 ($0.13). 1,096 shares were traded during mid-day trading, a decline of 97% from the average session volume of 33,390 shares. The stock had previously closed at GBX 9 ($0.12).

IXICO Trading Up 5.8%

The firm has a market cap of £8.82 million, a PE ratio of -2.47, a PEG ratio of -0.38 and a beta of 0.86. The business has a 50-day moving average price of GBX 8.68 and a two-hundred day moving average price of GBX 10.34. The company has a debt-to-equity ratio of 3.32, a current ratio of 2.85 and a quick ratio of 4.90.

IXICO (LON:IXI) last announced its quarterly earnings results on Tuesday, May 20th. The company reported GBX (1.11) (($0.01)) earnings per share for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. Analysts forecast that IXICO plc will post -289.3584879 EPS for the current year.

IXICO Company Profile

IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.

Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.